• 1. The regioselective iodination of quinolines, quinolones, pyridones, pyridines and uracil
  Uttam Dutta,Arghya Deb,David W. Lupton,Debabrata Maiti Chem. Commun. 2015 51 17744

Professional Introduction to 3-Iodo-8-nitroquinoline (CAS No. 497084-46-5)

3-Iodo-8-nitroquinoline, identified by the Chemical Abstracts Service Number (CAS No.) 497084-46-5, is a specialized organic compound that has garnered significant attention in the field of pharmaceutical chemistry and medicinal biology. This compound belongs to the quinoline derivatives family, which is well-documented for its diverse pharmacological properties and potential applications in drug discovery. The structural features of 3-Iodo-8-nitroquinoline, particularly the presence of both an iodine substituent and a nitro group, make it a versatile intermediate in synthetic chemistry and a promising candidate for further exploration in therapeutic contexts.

The molecular structure of 3-Iodo-8-nitroquinoline consists of a quinoline core substituted with an iodine atom at the 3-position and a nitro group at the 8-position. This specific arrangement imparts unique reactivity and functionality, making it valuable for various chemical transformations. The iodine atom, being electron-withdrawing, can participate in cross-coupling reactions such as Suzuki-Miyaura and Stille couplings, which are widely used in constructing complex organic molecules. Meanwhile, the nitro group can be reduced to an amine or converted into other functional groups, providing multiple pathways for structural diversification.

In recent years, 3-Iodo-8-nitroquinoline has been explored as a key intermediate in the synthesis of bioactive molecules. Its applications span across different therapeutic areas, including anticancer, antimicrobial, and anti-inflammatory agents. The quinoline scaffold is particularly recognized for its role in developing drugs that target bacterial infections and certain types of cancer. For instance, derivatives of quinoline have been instrumental in creating antibiotics like chloroquine and more recently, compounds investigated for their antiviral properties.

One of the most compelling aspects of 3-Iodo-8-nitroquinoline is its utility in designing molecules that interact with biological targets at the molecular level. The iodine substituent facilitates palladium-catalyzed cross-coupling reactions, enabling the introduction of various aryl or vinyl groups. This modularity allows chemists to fine-tune the properties of the resulting compounds, optimizing them for specific biological activities. For example, researchers have utilized 3-Iodo-8-nitroquinoline to develop inhibitors targeting enzymes overexpressed in cancer cells or to create probes for studying protein-protein interactions.

Recent studies have highlighted the potential of 3-Iodo-8-nitroquinoline in developing novel anticancer agents. Quinoline derivatives are known to disrupt DNA replication and interfere with metabolic pathways critical for tumor growth. By incorporating functional groups like iodine and nitro groups, chemists can enhance the binding affinity and selectivity of these compounds toward cancer-specific targets. Preclinical studies have demonstrated promising results with certain quinoline-based drugs in inhibiting tumor progression and inducing apoptosis in cancer cells.

The versatility of 3-Iodo-8-nitroquinoline also extends to antimicrobial applications. Quinolines have a long history as antimicrobial agents, with chloroquine being a classic example used to treat malaria. The structural modifications introduced by substituents like iodine and nitro groups can improve the efficacy of these compounds against resistant bacterial strains. Researchers are actively investigating quinoline derivatives as alternatives to conventional antibiotics, particularly in addressing multidrug-resistant infections.

Moreover, 3-Iodo-8-nitroquinoline has shown promise in anti-inflammatory drug development. Inflammation is a hallmark of many chronic diseases, including arthritis and autoimmune disorders. Quinoline derivatives can modulate inflammatory pathways by inhibiting key enzymes such as cyclooxygenase (COX) or lipoxygenase (LOX). The ability to introduce diverse functional groups into the quinoline core allows for the design of compounds with enhanced anti-inflammatory properties while minimizing side effects.

The synthesis of 3-Iodo-8-nitroquinoline typically involves multi-step organic transformations starting from commercially available precursors. Common synthetic routes include nitration followed by halogenation at specific positions on the quinoline ring. Advances in synthetic methodologies have enabled more efficient and scalable production processes, making 3-Iodo-8-nitroquinoline more accessible for research applications. These improvements have facilitated its use in high-throughput screening programs aimed at discovering novel bioactive molecules.

In conclusion,3-Iodo-8-nitroquinoline (CAS No. 497084-46-5) is a multifaceted compound with significant potential in pharmaceutical research and drug development. Its unique structural features enable diverse chemical modifications and biological applications, making it a valuable tool for medicinal chemists exploring new therapeutic strategies. As research continues to uncover novel uses for quinoline derivatives,3-Iodo-8-nitroquinoline is likely to remain at the forefront of innovation in medicinal chemistry.

• 607-35-2(8-Nitroquinoline)
• 42955-73-7(Acridine, 4-nitro-)
• 88609-20-5(6,8-Dinitroquinoline)
• 73868-15-2(8-Nitroquinolin-3-amine)
• 860757-90-0(8-iodo-5-nitroquinoline)
• 91804-76-1(2-nitrobenzo[f]quinoline)
• 908295-26-1(3-iodo-5-nitro-1h-indole)
• 12408-11-6(Quinoline, nitro-)
• 17576-53-3(3-Nitroquinoline)
• 5552-46-5(6-Iodo-8-nitroquinoline)